10 Jan 2022 CytoDyn plans a clinical trial in Chr
Post# of 148190
CytoDyn plans a clinical trial in Chronic fatigue syndrome
I found this interesting as well. Ohm20 had expressed that the FDA might be having problems with a Long-Hauler's trial protocol, because the symptoms are so varied and are at various levels of severity. Would running a trial for Chronic Fatigue Syndrome have better measurable symptoms and possibly improved measurement of efficacy? Then, if able to get approval, use off label for Long-Hauler's?